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me charge bu?Jlmg mode4 afmbu?eS me fQw &?f~bnllaInu, Ikfeshokl (RF?) Ol 
the bvhastc wauelomr lo lhq fall of ewess charge @ the. 2nd phase 
rnk5 nwckl pfec@cIs @at he tmnsm@nbtane potentfar change (Al/m) tof the 
best Mkwiec wwWms IS QepdafusIw durtnq fhe 1st phase kMowed by 
rc?MnotVmduringR\emd~~r~~~~~~~~~~~lst 
phase To test Ihis pte@cIhm, _\Vm dutmg a bqrhas% shock known m have a 
low OFT was recorded in 4 gwnea mg paptaary rm@es by a double-barrel 
B WIN& &minated the shy& amtact Foffowmg IO Si sf~muh i 
sfl ma brpoasic trurwated ex)mnential 52 shock (6 ms bme constant) of 4-6 
V/cm was given dunng Ihe pfaIeau of Ihe fasl Sl ac~mn pmtial Far sticks 
that depotad the memb+ane pdentlal ckmng Ihe 1st phase, 3Vml was 
the vcdlage btffefence behvevn Vm just before the shock and the maxImum 
Vm ctunng the 1st phase. 1Vm2 was tha voltage diflerence between Vm lust 
betore Ihe shuck and me mnnmum JVm dtmng me 2nd phase. 
Avmh 
f?esu/rs AVml was 51 : lSmVand.\Vm2was44 : 23mV(p. 005 
us. 0 mV) Thus. because at the nonl~oear rect~ly~ng propemes 01 lhe cell 
membrane. hyperpotanzason dunng the 2nd phase is almoal as large a$ 
depolaruation dunng ihe 1st phase (Fig). These findings do not ~ppcn the 
charge burping model wh!ch predicts lhat _\VmZ should be near zero for an 
eflrwnous biphasic waveform. 
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Prevalence-mctdence bias can ltmlt the generabzab!llty of cllnlcal mats It 
consists in the distortjon 01 the cknically relevant cohort of Incident cases by 
the preferential inclusfon of ‘avatlable’ prevalem cases Hnth better prognosis. 
AVID was a multicenter randomized trial companng ICDs vs. antianhythmlc 
drugs in 1.016 Sun/~vors 01 cardiac arrest or hemodynamlcelly compiwnrslry 
VT. In cknrcal praclice, the defimtive treatmenl 01 these pts is generally 
decided during the frrst week after the event. but the AVID enrollment window 
of up to 6 months opened the possibility for prevalence-Incidence bias. 
We compared the baseline characteristics and outcume of AVID ‘mcident” 
pts randomized within the first week (NC: n = 576) and ‘prevalent’ pts 
randomized 18 days alter the index event (PREV: n = 440). PREV pIS were 
more likely to have a prior history of VF (7% vs. 20b; p < 0.001). to undergo 
CABG (11% VS. 6%; p = O.QOl) or PTCA (596 VS. 2%: p = 0.009) after the 
index episode, to belong to a minority (17% vs. 10%: p = 0.002) and to be 
treated at a VA hcspital(l3% vs. 8%; p = 0.01). and IeSS likely to have prrvate 
insurance (33% vs. 41%; p = 0.01) or prior MI (63% vs. 70%; p = 0.001). 
Despite these differences, 2.year swvival was not significantly different (61 i 
4% in INC vs. 76 * 5% in PREV: p = 0.26: log-rank test). even altar adlusting 
for baseline variables and discharge treatment. 
Conc/us~ons In AVID, Iho time from the lndox ev%ni lo raodemrratw e- 
pended pamally an clmtcal. damographho and msttltuttonal factors However 
pts randomlxed later after the mcfsx event did nal represent a lowor.rt& group 
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UndergoIng Acthrr Can hnpkntabk CadW 
tWlbdlater hnplent8tbn 
A#@!#& We eoughr IO determine Ihe= magmtude of v6nallCe In ULV 
In 63 MHIgecullW PI ur&?rgotng ICD Itnplanlahon. We mearmrad ULV as 
the strengm 41 OI above whfch vanlnculat IibnllatKHI 18 not induced when a 
sttlmuluue IS dekvered 31Q ma affer m fJ beat venmcular pacmg drive Iram et 
400 ms. We meaoured defibnllatron lhreahold (DFT) in pt wlM an aclrve can 
devrca lrsmg a bphasrc wave form and Ihe bmary 5earch maIho@ 
&suns: The mean age was 63 + 12 years. and mean e+zflon fractron 
was 35 * 15%. The mean ULV was 8.7 f 5 4 @es (J) and fhe mean DFT 
was IO.0 2 4.9.l fech pI had 4.5 * 0.6 ULV measurements. Monophas~ 
ULV coneta@d poorty wl(h btphasie OFT (R = 0 27. p = 0 04). Change m 
ULV was calculalad from Iha IlrsI to second $+?cond IO I!xrd. fhlrd to foufih 
andhrst~llirstmeasurenrenhi.Themean~o~pt~hm,cha~w~300~~. 
wxth a change of l-3 J was 57%. and with a change of 3 J was 13%. ?%a 
mtracfasa conelatmn co@rcrenI of reSab#lny was 0.21 which m&oates a large 
vanance m Ihe measurement ol ULV 
Summary: Monophasrc ULV% ba not wrrelate well wnth MPhaSlc actwa 
can DOTS. High DFT’s were predicted ty hrgh ULv’5. but a Comldereble 
vanatwn m [he acute measuremen of ULV ex1s(6- l?xse hn6fngs ha@ 
Importam rmpkcatlons tar research usln~ ULV 
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While echocardrograpby (2DE) 1s often uoed IO evaluete patrents (pIs) ~nth 
syncope~I$~lltlyrnIhtsarearsnot welldehned. Indeed. Ifrecurrent ACC/AAHA 
Gurdelines for the Clinrcal Applrcatton of EchocardIography nolo a ‘strung 
need”foralargepmspectlve study In this area. To eddress thr~ mue. 259 
c~nSecuttve ptS (age 67 f 16 yr~) admitted 10 Il?e emergency deparhrrent 
wtth syncope were evaluated wtth ZDE. 2DE findings ware mvh?wed In lhe 
context of dintcal data mcludmg history. phySical examtnatkm. EKG. and. 
when avallable. Hotter and/or electmphVs~&g~c evaluation. The diagnostic 
yield 01 2DE was categorized as. I . ldentlfled abnarmallty fell to be sole 
cause 01 syncope. II _ @?nt#ted abnormaltty cantnbuhng 10 syncope in pts 
with co-extsteot anhytma. Ill -demonstrated no perlInen abnOmX3llty 
Results: The dragnostlc yreld was I . 78?0. II - 12%. 111 - 80.2% ZDE 
diagnoses m category I mcluded severe aortlc steno% IHSS. severe pul- 
monary hypertension. and acute pulmonary embotll. CategorY II pattents 
mcluded those wrth mbld to moderate AS. acute my0cafdlal InferchoR moder- 
ate to targs pemardtel effuston. end prevtously umuspectad kn vmbmki~ 
dysfunct!on m whom ventncular or atnal anhythmla was demonStfZited. 
Concrus~ons. In pts with syncope. 2DE pmvldes usetul dlagnostlc mIOr. 
mation In 19 6% In 7 6%. thts lntormatton 8s diagnostic These data SutJPJfl 
a role for 2DE In pts wxth syncope. However m pts In whom a non*ardzK 
cause of syncope is apparent and there IS no clmrcal SuspinOn Of heart 
disease. the test may be inappmpnate. 
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